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ARTICLE
CRACR2a is a calcium-activated dynein adaptor
protein that regulates endocytic traffic
Yuxiao Wang1,2, Walter Huynh1,2, Taylor D. Skokan1,2, Wen Lu3, Arthur Weiss2,3, and Ronald D. Vale1,2
Cytoplasmic dynein is a minus end–directed microtubule motor that transports intracellular cargoes. Transport is initiated by
coiled-coil adaptors that (a) join dynein and its cofactor dynactin into a motile complex and (b) interact with a cargo-bound
receptor, which is frequently a Rab GTPase on an organelle. Here, we report two novel dynein adaptors, CRACR2a and Rab45,
that have a coiled-coil adaptor domain, a pair of EF-hands, and a Rab GTPase fused into a single polypeptide. CRACR2a-
mediated, but not Rab45-mediated, dynein motility is activated by calcium in vitro. In Jurkat T cells, elevation of intracellular
calcium activates CRACR2a-mediated dynein transport. We further found that T cell receptor activation induces the
formation of CRACR2a puncta at the plasma membrane, which initially associate with the actin cortex and subsequently
detach and travel along microtubules, suggestive of an endocytic process. These results provide the first examples of Rab
GTPases that directly act as dynein adaptors and implicate CRACR2a–dynein in calcium-regulated endocytic trafficking.
Introduction
Microtubule-based transport is essential for the positioning of
large membrane organelles, the trafficking of small transport
vesicles, and the localization of mRNA and protein (Schliwa and
Woehlke, 2003; Vale, 2003). Microtubules are polarized fila-
ments with distinct plus and minus ends; in most cells, micro-
tubule plus ends extend to the cell periphery andminus ends are
anchored to the microtubule-organizating center (MTOC). Plus
end–directed transport is mediated by kinesin, a large family of
motor proteins with >40members inmammals (Hirokawa et al.,
2009). In contrast, all minus end–directed intracellular trans-
port in animal cells is performed by a single motor protein
complex, cytoplasmic dynein-1 (referred to as dynein hereafter;
Vale, 2003; Reck-Peterson et al., 2018). Most, if not all, mem-
brane organelles are transported by dynein (Reck-Peterson
et al., 2018).
The dynein holoenzyme is composed of an ∼500-kD heavy
chain and five smaller subunits (three light chains, one light-
intermediate chain, and one intermediate chain). Mammalian
dynein does not display processive motility, owing to auto-
inhibition of its motor domain (Zhang et al., 2017). Binding of the
dynactin complex and an adaptor protein activates dynein, en-
abling it to move processively along microtubules (McKenney
et al., 2014; Schlager et al., 2014). Thus far, eight adaptors have
been demonstrated to directly bind and activate dynein: BicDL1,
BicD2, Hook1, Hook3, Rab11FIP3, Spindly, Ninein, and Ninein-
like protein (Reck-Peterson et al., 2018). A common feature of
these proteins is the presence of long coiled-coil domains.
Structural studies revealed that the coiled-coils of BicD and Hook
are directly involved in joining dynein and dynactin together
into a tripartite complex (Urnavicius et al., 2015, 2018).
Recruitment of the dynein–dynactin adaptor complex to
specific membrane organelles is often mediated by the interac-
tion between a dynein adaptor and a Rab GTPase, which asso-
ciates with intracellular membrane compartments through
C-terminal prenylation (Hutagalung and Novick, 2011; Reck-
Peterson et al., 2018). Rab GTPases have been shown to regu-
late the localization as well as the conformation of dynein
adaptors. Rab6, which localizes to Golgi-derived vesicles, re-
cruits the dynein adaptor BicD to mediate retrograde transport
(Matanis et al., 2002). Binding of Rab6 to BicD also alleviates its
autoinhibition and promotes BicD-mediated dynein–dynactin
activation (Hoogenraad et al., 2003; Liu et al., 2013; Huynh and
Vale, 2017). Thus far, no Rab has been shown to possess the
ability to interact with and activate dynein–dynactin directly.
Here, we report the discovery of two novel dynein adaptor
proteins, Rab45 and CRACR2a, both of which are also Rab
GTPases (Srikanth et al., 2017). These are the first identified
dynein–dynactin adaptors that contain both a Rab GTPase
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domain and a coiled-coiled dynein–dynactin activator domain.
We found that the ability of CRACR2a to activate dynein–
dynactin is stimulated by physiological concentrations of calci-
um. CRACR2a was initially identified as a 46-kD cytosolic pro-
tein that regulates CRAC channel activation in T cells (Srikanth
et al., 2010). Subsequently, a longer 90-kD isoform of CRACR2a
was identified that localizes to vesicles that translocate toward
the immunological synapse (IS) and regulate JNK activation
downstream of the T cell receptor (TCR; Srikanth et al., 2016).
Examining the localization of the long isoform of CRACR2a in
activated Jurkat T cells, we found an additional population of
CRACR2a that forms distinct puncta that migrate with actin
retrograde flow at the IS and that require microtubules to detach
from the actin cortex and move toward the MTOC. We provide
evidence suggesting that the formation of CRACR2a puncta is a
clathrin-independent process, and that CRACR2a may be in-
volved in the endocytic transport of the cell surface molecule
CD47. Together, our results demonstrate that Rab45 and CRACR2a
constitute a new class of dynein adaptors and reveal a role of
CRACR2a and dynein in endocytic traffic.
Results
Identification of Rab45 and CRACR2a as activating adaptors
for dynein
Rab45 and CRACR2a are atypical Rab GTPases that contain a pair
of EF-hand domains, a coiled-coil domain, and a Rab GTPase
domain (Fig. 1 A). We speculated that these proteins may func-
tion as dynein adaptor proteins due to (a) their domain archi-
tecture (EF-hands followed by coiled-coils), which resembles
that of known dynein adaptors, such as Rab11FIP3 and Ninein
(Fig. 1 A), and (b) their localization to a small, perinuclear
compartment at the cell center, suggestive of microtubule minus
end–directed transport (Shintani et al., 2007; Srikanth et al.,
2016). The human CRACR2a gene was shown to undergo alter-
native splicing to produce two isoforms (Wilson et al., 2015;
Srikanth et al., 2016). In this study, we focused on the long
isoform, as the short isoform lacks the Rab GTPase domain and
does not seem to be involved in membrane trafficking (Srikanth
et al., 2016).
We first sought to determine whether Rab45 and CRACR2a
could interact with dynein and dynactin. To this end, we ex-
pressed and purified Rab45 and CRACR2a fused with a Strep-tag
and superfolder GFP (Fig. S1 A), attached these proteins to
StrepTactin beads, and then performed pulldown assays with
dynein–dynactin isolated from RPE1 cells. Indeed, both Rab45
and CRACR2a interacted with dynein–dynactin in these pull-
down assays (Fig. 1 B).
We next examined the ability of Rab45 and CRACR2a to ac-
tivate the processive motility of native dynein–dynactin using
an established total internal reflection fluorescence (TIRF) mi-
croscopy single-molecule assay (McKenney et al., 2014; Huynh
and Vale, 2017). Purified Rab45 and CRACR2a robustly activated
the processive motility of dynein–dynactin on microtubules
(Fig. 1, C and D), similar to other known dynein adaptors
(McKenney et al., 2014; Schlager et al., 2014; Redwine et al.,
2017). The velocities of movement were 0.99 ± 0.21 µm/s and
0.67 ± 0.25 µm/s (mean ± SD) for Rab45 and CRACR2a, re-
spectively. Together, these data indicate that Rab45 and CRACR2a
can bind to dynein–dynactin and activate dynein motility
in vitro.
To determine whether Rab45 and CRACR2a activate dynein
transport in cells, we employed a previously developed inducible
peroxisome trafficking assay, in which a candidate adaptor
protein is induced to localize to peroxisomes by addition of ra-
pamycin (Kapitein et al., 2010; Fig. 1 E). In the absence of ra-
pamycin, peroxisomes are distributed randomly throughout the
cell (Fig. 1 F). Recruitment of a dynein adaptor to peroxisomes
causes them to move toward the microtubule minus end and
accumulate around the MTOC (Fig. 1 E). We found that
rapamycin-induced targeting of Rab45 and CRACR2a to perox-
isomes resulted in strong clustering of peroxisomes at the cell
center (Fig. 1 F), suggesting that Rab45 and CRACR2a are capable
of recruiting dynein and activating dynein-mediated transport
in cells.
Regulation of the dynein adaptor function of Rab45 and
CRACR2a by calcium
The presence of EF-hands, a known calcium binding motif, in
Rab45 and CRACR2a led us to examine whether calcium regu-
lates their function as dynein adaptors. In the previous pulldown
and single-molecule assays (Fig. 1, B and C), we did not add
calcium or EGTA, in which case trace amounts of calcium at
micromolar levels could still be present in the buffer (Bers et al.,
2010).We therefore repeated the dynein–dynactin binding assay
either with 2 mM EGTA, to deplete calcium completely, or with
2 µM free calcium (buffered by EGTA:Ca2+), a concentration
relevant for most calcium-dependent physiological processes
(Bers et al., 2010; see Materials and methods for details). While
complex formation between Rab45 and dynein–dynactin was
insensitive to calcium, CRACR2a required the presence of cal-
cium for stable interaction with dynein and dynactin (Fig. 2 A).
In addition, mutating the calcium binding sites in the EF-hands
of CRACR2a (CRACR2AEFmut) abolished its interaction with
dynein–dynactin, regardless of calcium concentration (Fig. 2 A).
We further tested whether the single-molecule motility of
CRACR2a–dynein–dynactin responds to changes of calcium in
the physiological range (100 nM to ∼10 µM). Raising calcium
concentration from 10 nM to 2 µM significantly increased the
number of processive events on microtubules (Fig. 2 B), con-
sistent with the calcium-dependent stabilization of CRACR2a–
dynein–dynactin complex as shown in the pulldown assay. In
contrast, the motility of Rab45-dynein–dynactin was similar in
the presence of EGTA or 2 µM calcium (Fig. S1). Taken together,
these results suggest that the dynein adaptor function of CRACR2a
is activated by physiological levels of calcium.
T cell activation–induced calcium elevation stimulates the
transport of CRACR2a toward the MTOC
Intrigued by the regulation of CRACR2a-mediated dynein mo-
tility by calcium in vitro, we decided to further pursue in vivo
studies of this adaptor protein. CRACR2a is highly expressed in
primary T cells as well as in the Jurkat T cell line (Srikanth et al.,
2016). We observed that GFP-CRACR2a stably expressed in
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Jurkat localized to a loosely connected membrane compartment
surrounding theMTOC (Fig. 3 A), as well as to small vesicles that
traveled bidirectionally along microtubules, consistent with
observations made by Srikanth et al. (2016) (Video 1 and Fig. 3
A). We also found GFP-CRACR2a diffusely localized throughout
the cytoplasm (Video 1 and Fig. 3 A). Western blot with endog-
enous antibody showed that GFP-CRACR2a remained full length
and was expressed at roughly the same level of the endogenous
CRACR2a, suggesting that the cytosolic CRACR2a was not due to
protein degradation or overexpression (Fig. S2 B). It is possible
that the cytosolic CRACR2a was GDP bound and unable to as-
sociate with membrane, as shown by Srikanth et al. (2016).
We next sought to examine whether CRACR2a in Jurkat
T cells responds to changes in intracellular calcium. The GFP-
CRACR2a vesicular compartment was loosely associated with
theMTOC in resting Jurkat cells (Fig. 3 A). Treatment of the cells
with ionomycin, which elevates cytoplasmic calcium, caused
GFP-CRACR2a to further concentrate at a small region adjacent
to theMTOC (Fig. 3, A and B). To test if the EF-hands in CRACR2a
are responsible for such calcium-dependent MTOC congregation,
Figure 1. Rab45 and CRACR2a are adaptor pro-
teins for dynein. (A) Domain organizations of
Rab45, CRACR2a, Rab11FIP3, and Ninein. EF, EF-
hand; CC, coiled-coil. Sizes of the domains are not
to scale. (B) Pulldown assay shows that Rab45 and
CRACR2a bind to dynein–dynactin. DHC, dynein
heavy chain; p150, the p150 subunit of dynactin.
Western bands are from the same gel. (C) Sample
kymographs of microtubule-based motility of Rab45
or CRACR2a in complex with dynein–dynactin. Fluo-
rescence is from the N-terminal GFP tag on Rab45 or
CRACR2a. (D) Quantification of the velocities of
dynein–dynactin in complex with Rab45 or CRACR2a.
Error bar: SD; n = 40 processive particles from three
replicates. (E) Schematic of the inducible peroxi-
some trafficking assay. U2OS cells were transfected
to express GFP-FRB fused with a peroxisome tar-
geting sequence (PEX) and an mCherry-adaptor-
FKBP construct. Treatment of the cell with rapamycin
induces the localization of the dynein–dynactin adap-
tor complex to peroxisomes and drives retrograde
transport of peroxisomes toward the microtubule
minus end. (F) Representative images of the per-
oxisome transport assay (scale bar: 10 µm). +Rapa,
treatment with rapamycin. Quantifications of the
percentage of cells with a strong perinuclear cluster
of peroxisomes are shown on the right. Data are
mean ± SEM of three independent experiments (n =
30–40 cells per experiment). ****, P < 0.0001 be-
tween DMSO-treated group and rapamycin-treated
group using two-way ANOVA analysis with Sidak’s
multiple comparisons test.
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we generated a CRACR2a knockout Jurkat cell line, J.CRACR2a,
using CRISPR/Cas9 (Fig. S2), and reintroduced GFP-CRACR2aEFmut.
Disruption of the calcium-binding sites in the EF-hands completely
abolished ionomycin-induced MTOC clustering of GFP-CRACR2a
(Fig. 3, B and C), consistent with the in vitro observation that
CRACR2aEFmut failed to bind to dynein–dynactin (Fig. 2 A). To test
the notion that the calcium-stimulated accumulation of CRACR2a
at the MTOC is caused by an increase of retrograde transport
of CRACR2a-bound vesicles (and not cytosolic GFP-CRACR2a),
we expressed a GFP-CRACR2a mutant lacking the C-terminal
polybasic region and prenylation motif (GFP-CRACR2aΔtail) in
wild-type Jurkat cells. As expected, GFP-CRACR2aΔtail was com-
pletely diffusive in the cytoplasm (Fig. 3 B). Moreover, ionomycin
treatment failed to induce clustering of GFP-CRACR2aΔtail at the
MTOC (Fig. 3, B and C), suggesting that membrane association of
CRACR2a mediated by prenylation is essential for the observed
accumulation of CRACR2a at the MTOC in response to calcium
elevation.
TCR activation induces a rapid increase of intracellular
free calcium to initiate downstream signaling. To determine if
CRACR2a dynamics are altered during TCR triggering, we
stimulated Jurkat cells expressing GFP-CRACR2a with immobi-
lized anti-CD3ε antibody (clone OKT3). T cell activation induced
a rapid congregation of GFP-CRACR2a at theMTOC (Fig. 3, D and
E), similar to what was observed with ionomycin treatment.
Chelation of extracellular and intracellular calcium by EGTA and
BAPTA, as well as mutation of the calcium-binding sites in the
EF-hands of CRACR2a, abolished the ability of TCR activation to
cause CRACR2a clustering at the MTOC (Fig. 3, D and E). These
results indicate that, in response to calcium increase induced by
TCR activation, CRACR2a recruits and activates dynein to un-
dergo retrograde transport toward the MTOC.
Activation of a T cell by an antigen-presenting cell leads to
the formation of a specialized cell–cell junction known as the IS
(Dustin et al., 2010). A previous study reported that during T cell
activation CRACR2a vesicles translocate toward the IS (Srikanth
et al., 2016). We stimulated Jurkat cells with immobilized anti-
CD3 and examined the dynamics of CRACR2a at the IS using
TIRF microscopy, which only illuminates regions adjacent to the
basal cell membrane. We observed that the MTOC and the ve-
sicular compartment of CRACR2a migrated together into the
TIRF field and docked at the center of the IS (Fig. S3 B). This
suggests that the previously reported translocation of GFP-
CRACR2a is likely due to the movement of the MTOC toward
the IS, which brings with it most of the microtubule network
and the endomembrane system (Stinchcombe and Griffiths,
2014).
We sought to determine whether the CRACR2a vesicular
compartment at the MTOC colocalizes with known membrane
organelles. An earlier study suggested that CRACR2a colocalized
with the Rab8-positive trans-Golgi network in T cells (Srikanth
et al., 2016). Although GFP-CRACR2a and mCherry-Rab8 in
Jurkat cells both localized to the perinuclear region, high-
resolution confocal imaging revealed little colocalization
between the two proteins (Fig. S4 A). In addition, ionomycin
treatment did not change the distribution of Rab8A, whereas it
strongly compacted CRACR2a-containing membrane compart-
ments at the MTOC (Fig. S4, A and B). We further tested the
colocalization between CRACR2a and Rab11A, which localizes to
perinuclear recycling endosomes. In the basal state, CRACR2a
appears to partially colocalize with Rab11A (Fig. S4 C). However,
upon ionomycin stimulation, only CRACR2a, and not Rab11A,
relocalized and became tightly clustered at the MTOC (Fig. S4, C
and D). These results together suggest that the subcellular lo-
calization of CRACR2a is distinct from that of Rab8 or Rab11.
T cell activation promotes the formation of CRACR2a puncta at
the cell cortex
When examining the dynamics of CRACR2a at the IS by
TIRF microscopy, we also observed the formation of dim and
Figure 2. Regulation of the dynein adaptor function of CRACR2a by calcium. (A) Dynein–dynactin pulldown assays performed with calcium-depleted
buffer (2 mM EGTA) or buffer containing 2 µM free calcium. DHC, dynein heavy chain; p150, the p150 subunit of dynactin.Western bands are from the same gel.
(B) Quantification of CRACR2a–dynein–dynactin motility at different free calcium concentrations. Data were collected from three replicates, with each calcium
condition measuring at least 25 microtubules. Error bar: SEM. **, P < 0.01; ****, P < 0.0001, one-way ANOVA and Dunnett’s test versus zero free calcium
condition. Example kymographs are shown on the right.
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diffraction-limited GFP-CRACR2a puncta at the cell periphery
(Fig. 4 A). These puncta were difficult to resolve under a confocal
microscope, but visible when imaged using TIRF microscopy,
suggesting that they are at or adjacent to the plasma membrane.
Notably, these puncta were morphologically distinct from the
CRACR2a vesicular compartments described earlier, which are
relatively large and enter into the TIRF field at the center of the
cell (Fig. S3 B). We refer to the plasma membrane localized
CRACR2a as “cortical puncta” to distinguish them from the pool
of CRACR2a localized to intracellular vesicles.
To determine whether T cell signaling regulates the forma-
tion of CRACR2a cortical puncta, we plated Jurkat cells onto
isotype control antibody-coated glass and observed very few
cortical puncta at the cell membrane (Fig. 4 B). Addition of
Figure 3. Calcium regulation of CRACR2a subcellular localization in T cells. (A) Changes in CRACR2a localization before and after ionomycin treatment, as
well as the method used for quantification of the distribution of CRACR2a adjacent to the MTOC. The same cell before and after ionomycin treatment is shown.
MTOC is visualized by staining with 100 nM SiR-Tubulin for 4 h and adjusting the intensity scale of the image to show only high-intensity pixels (see Fig. S3 A).
MTOC enrichment ratio is defined as the ratio of mean GFP intensity within a 0.5-µm region of the MTOC versus the mean GFP intensity within a 0.5-µm to
∼2.5-µm region of the MTOC. Scale bar: 5 µm. Inset scale bar: 1 µm. (B) Mutational study of CRACR2a clustering at the MTOC. EFmut, J.CRACR2a cell line
expressing GFP-CRACR2a with mutated calcium-binding site in EF-hands (D63A, E65A, D97A, D99A). ΔTail, wild-type Jurkat line expressing GFP-CRACR2a with
a deletion of C-terminal tail (Δ725–731). Scale bar: 10 µm. (C)Quantifications of relative enrichment of CRACR2a at the MTOC for experiments shown in B. Data
are mean ± SEM of three independent experiments (n = 11–30 cells per group in each experiment). ****, P < 0.0001, two-way ANOVA with Sidak’s multiple
comparisons test. (D) T cell activation induces clustering of CRACR2a compartments at the MTOC. Scale bar: 10 µm. (E) Quantifications of the levels of relative
enrichment at MTOC for experiments shown in D. Data are mean ± SEM of three independent experiments (n = 10–30 cells per group in each experiment).
**, P < 0.01, one-way ANOVA with Dunnett’s test comparing each sample with sample #1.
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ionomycin in this condition stimulated the formation of the
cortical puncta (Fig. 4 B). In contrast, depletion of both extra-
cellular and cytoplasmic calcium by EGTA/BAPTA blocked the
formation of cortical puncta when cells were activated by im-
mobilized anti-CD3 (Fig. 4 B). These results suggest that the
formation of CRACR2a cortical puncta at the IS is stimulated by
TCR activation–induced calcium elevation.
CRACR2a cortical puncta are distinct from previously
characterized endosomal and Golgi-derived vesicles
To further explore the identity of the CRACR2a cortical puncta,
we examinedwhether they colocalize withmarkers for different
endosomal populations, including clathrin light-chain (clathrin-
coated pits and vesicles), Rab5A (early endosomes), Rab11A
(recycling endosomes), and Rab22A and Arf6 (clathrin-
independent endosomes; Ferreira and Boucrot, 2017; Johnson
et al., 2017). We did not observe colocalization between the
cortical puncta and any of these markers (Fig. 5 A). Srikanth
et al. (2016) also reported that CRACR2a forms vesicles that
translocate from the Golgi to the IS. To test whether the cortical
puncta are Golgi-derived transport vesicles, we blocked post-Golgi
trafficking with Brefeldin A (Miller et al., 1992). The forma-
tion of CRACR2a cortical puncta was not affected by Brefeldin
A treatment, suggesting that they are not Golgi-derived vesicles
(Fig. 5 B).
We further treated the cells with a panel of chemical in-
hibitors that disrupt clathrin-coated pit formation (chlorprom-
azine or PitSTOP2) or caveolae-mediated uptake (Filipin III).
None of these inhibitors affected the number of the cortical
puncta observed (Fig. 5 B). In contrast, inhibition of actin po-
lymerization (with 2 µM latrunculin A [LatA] or 5 µM cyto-
chalasin B) completely abolished the appearance of CRACR2a
cortical puncta (Fig. 5 B). Dynamin GTPases are involved in the
formation of clathrin-dependent and a subset of clathrin-
independent endosomes (Doherty and McMahon, 2009). Inhi-
bition of dynamin function by overexpression of the K44A
dominant-negativemutant of dynamin (DynK44A) caused a 40%
reduction of the number of the cortical puncta, while MiTMAB,
a chemical inhibitor of dynamin function, did not have any ef-
fect, indicating that the formation of the cortical puncta could be
partially dynamin dependent (Fig. 5 B). Together, these results
suggest that the CRACR2a cortical puncta are formed through a
clathrin-independent, caveolin-independent but actin-dependent
pathway.
CRACR2a cortical puncta comigrate with F-actin retrograde
flow at the IS
The CRACR2a cortical puncta in the TIRF field emerged from the
distal edge of the lamella andmigrated centripetally (Fig. 6 A and
Video 2). Activation of the TCR leads to rapid polymerization of
F-actin at the perimeter of the IS, resulting in robust retrograde
actin flow (Yi et al., 2012). To understand the relation of CRACR2a
cortical puncta to actin, we visualized both GFP-CRACR2a and
mCherry-F-tractin, a probe for filamentous actin (Yi et al.,
2012). The cortical puncta comigrated with the retrograde
flow of actin at the IS (Fig. 6 A and Video 3) with similar speeds
(cortical puncta, 0.068 ± 0.023 µm/s; F-actin, 0.065 ± 0.025 µm/s,
mean ± SD; Fig. 6 B). Disruption of F-actin using LatA (2 µM)
rapidly abolished the formation of new cortical puncta, as well
as the centripetal movement of preexisting cortical puncta
(Fig. 6 A and Video 4). These results suggest that actin is in-
volved in the formation of CRACR2a cortical puncta and drives
their retrograde flow to the center of the IS.
CRACR2a cortical puncta recruit dynein to detach from the
actin cortex and travel to the MTOC
Given our earlier result that CRACR2a is an adaptor for dynein,
we wondered whether dynein was recruited to CRACR2a cor-
tical puncta. Coexpression of mCherry-tagged dynein light chain
Tctex3 showed that dynein localized to the cortical puncta im-
mediately after their appearance at the edge of the cell (Fig. 7 A
and Video 5). We reexamined the dynamics of the cortical
puncta using a spinning disk confocal microscope with fluor-
escent labeling of actin and microtubules. High cytosolic fluo-
rescence signal and fast photobleaching precluded precise
tracking of the movement of each punctum. Nevertheless,
Figure 4. T cell activation promotes the formation of CRACR2a puncta at the cell cortex. (A) Formation of CRACR2a cortical puncta at the periphery of
the IS. Scale bar: 5 µm. (B)Quantification of the number of observed CRACR2a cortical puncta when Jurkat cells are stimulated by different conditions. Control,
IgG isotype control; Iono, stimulation with ionomycin/calcium. n = 29–41 ROIs from at least 20 cells collected during three independent experiments. Error bar
indicates SEM. ****, P < 0.0001, one-way ANOVA with Tukey’s multiple comparisons test.
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occasionally we could observe that a slowly migrating CRACR2a
cortical punctum abruptly switched to fast retrograde move-
ment on microtubules toward the MTOC (Fig. 7 B). Depoly-
merization of microtubules by nocodazole treatment did not
affect the retrograde movement of CRACR2a cortical puncta
at the peripheral region of the IS (Video 6). However, under
these conditions, CRACR2a failed to form a tight cluster at the
MTOC, but instead accumulated within the TIRF field (<200-nm
zone near the plasma membrane) at the actin-depleted region
of the IS to form a disk-like structure (Fig. 7 C and Video 6).
Further disruption of F-actin in nocodazole-treated cells
caused the accumulated cortical puncta to disperse from the
disk-like structure (Fig. 7 C), suggesting that the cortical
puncta remain associated with the actin cortex when micro-
tubules are absent. Taken together, the above results indicate
that microtubule-based transport is important for the cortical
puncta to dissociate from the actin cortex and move toward
the MTOC.
Figure 5. CRACR2a cortical puncta are distinct from previously characterized endosomal and Golgi-derived vesicles. (A) CRACR2a cortical puncta
(indicated by yellow arrowheads) do not colocalize with Rab5, Rab11, Rab22, Arf6, or clathrin-coated pits (indicated by white arrowheads). Scale bar: 3 µm.
(B) Quantifications of the number of CRACR2a puncta observed in activated Jurkat cells under different treatments. DynK44A, coexpression of the K44A
dominant-negative mutant of dynamin 1; n = 15–48 ROIs from at least 20 cells collected during three independent experiments. Error bar indicates SEM.
****, P < 0.0001, one-way ANOVA with Dunnett’s multiple comparisons test comparing each sample with mock (DMSO) treated sample.
Figure 6. CRACR2a cortical puncta comigrate with F-actin retrograde flow at the IS. (A) GFP-CRACR2a puncta migrate with actin retrograde flow. GFP-
CRACR2a-expressing Jurkat cells were allowed to settle on anti-CD3–coated glass and were either not treated or treated with 2 µM LatA for 5 min to de-
polymerize actin. Kymographs are derived from the yellow dashed lines indicated on the images. Scale bar: 10 µm. (B) Velocities of the CRACR2a cortical
puncta and actin retrograde flow. Velocities are quantified based on at least 50 kymograph traces from eight cells in each condition. Data are mean ± SD.
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CRACR2a is involved in endosomal trafficking of CD47
The formation of CRACR2a cortical puncta at the plasma mem-
brane and their microtubule-dependent movement away from
the cortex and toward the cell interior suggests that CRACR2a
might be involved in endocytosis. We sought to identify cell
surface proteins that undergo endocytosis and colocalize with
the CRACR2a vesicular compartment inside the cell. We selected
a set of candidate molecules, with distinct membrane topologies,
that have been shown previously to be internalized through
various endocytic pathways (Maldonado-Ba´ez et al., 2013;
Boucrot et al., 2015; Table 1). We employed an antibody/ligand
internalization assay to examine the endocytosis of cell surface
molecules. Briefly, endocytosis was suppressed by incubating
cells on ice, and cell surface proteins were labeled on the ex-
tracellular side using fluorescent-conjugated antibodies or lig-
and. Excess labeling antibodies/ligands were then removed.
Cells were warmed to 37°C rapidly and stimulated with immo-
bilized anti-CD3 antibodies to promote endocytosis and trans-
port to theMTOC. The amount of internalized antibody or ligand
within the CRACR2a compartment was determined by confocal
imaging. Among the candidates tested, only the multipass
transmembrane protein CD47 was strongly internalized into the
CRACR2a compartment at the MTOC (Fig. 8, A and B). Confocal
z-sections of the cells confirmed that the cell surface–labeled
CD47 was indeed internalized into the interior of the cell (Fig.
S5). Stimulation of Jurkat cells with ionomycin alone also pro-
moted internalization of CD47 into the CRACR2a compartment
(Fig. 8, C and D).
We further examined the internalization of CD47 in wild-
type Jurkat T cells or in the CRACR2a knockout cell line,
J.CRACR2a. Qualitatively, antibody-labeled CD47 could still be
observed within endocytic vesicles in J.CRACR2a (Fig. 8 E). This
could be due to the presence of CRACR2a-independent endocytic
pathways that also mediate the internalization of CD47. We
therefore quantified the amount of internalized CD47 trans-
ported to within 2.5 µm of the MTOC, the region where the
majority of the CRACR2a vesicular compartments concentrate
(Fig. 3 A). Deletion of CRACR2a significantly reduced the amount
of CD47 within this region (Fig. 8 E), which could result from a
reduction in CD47 endocytosis and/or retrograde transport of
Figure 7. CRACR2a cortical puncta recruit dynein to detach from the actin cortex and travel to theMTOC. (A) Colocalization between CRACR2a cortical
puncta and dynein (visualized by mCherry-Tctex3, a dynein light chain). Scale bar: 5 µm. Inset scale bar: 2 µm. (B) Imaging CRACR2a cortical puncta dynamics
on actin (visualized by mCherry-F-tractin) and microtubules (visualized by SiR-Tubulin) using a spinning disk confocal microscope. Kymograph analysis along
the indicated line is shown on the right. In total, 28 cells were imaged continuously for 50 s each, and 16 events of a cortical punctum moving on a microtubule
were observed. Scale bar: 5 µm. (C) Changes in CRACR2a cortical puncta dynamics in response to cytoskeleton disassembly by nocodazole (5 µM) and/or
latrunculin A (2 µM). The cells are treated as indicated by the diagrams shown on the left side. Scale bar: 5 µm.
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CD47-positive endosomes after internalization. Taking these
results together, we propose that CRACR2a is involved in a form
of calcium-stimulated endocytic process, and that CD47 is one of
the cargoes transported through this pathway.
Discussion
In this study, we provide evidence that the Rab GTPases CRACR2a
and Rab45 are unusual adaptor proteins that activate dynein–
dynactin motility. Several Rab GTPases have been shown to
bind directly to dynein adaptor proteins. Rab6, for example,
binds to the C-terminal coiled-coil of the adaptor BicD, which
then uses its N-terminal coiled-coil to engage dynein–dynactin
(Matanis et al., 2002; Urnavicius et al., 2015; Huynh and Vale,
2017). Rab11FIP3 has an N-terminal EF-hands and a coiled-coil
for dynein activation, while containing a C-terminal Rab11-
binding domain (Horgan et al., 2010; McKenney et al., 2014).
In these examples, the Rab binding domains themselves do not
appear to contribute directly to binding of dynein–dynactin;
instead they mainly act to recruit the adaptors to specific
membrane cargoes (Reck-Peterson et al., 2018). Our evidence
indicates that CRACR2a and Rab45 represent gene fusions of a
Table 1. Candidate cell surface proteins tested for internalization into CRACR2a vesicular compartment
Transferrin receptor TCR CD47 CD59 CD147
Type Type II single transmembrane
protein (dimer)
Multichain receptor
complex
Five-pass transmembrane
protein
GPI-anchored cell
surface protein
Type I single
transmembrane protein
Endocytic
pathway
CME CME and CIE CIE?a CIE CIE
CIE, clathrin-independent endocytosis; CME, clathrin-mediated endocytosis.
aListed as CIE cargo in Boucrot et al. (2015), but no primary data could be found.
Figure 8. CRACR2a is involved in endosomal trafficking of CD47. (A) CD47 but not Transferin (Tfn) is internalized into CRACR2a compartment at the
MTOC. Scale bar: 5 µm. Inset scale bar: 2 µm. (B) Quantification of the fraction of internalized receptor that colocalizes with the CRACR2a compartment. Data
are from at least 18 cells collected during three independent experiments. Errors bar indicate SEM.(C) Ionomycin stimulates CD47 internalization into CRACR2a
compartment. Scale bar: 10 µm. (D) Quantifications of the fraction of internalized CD47 in CRACR2a compartment in EGTA or ionomycin condition. Data are
from at least 20 cells collected during three independent experiments. Error bar indicates SEM. **, P < 0.01, Student’s t test. (E) Deletion of CRACR2a reduced
the amount of CD47 internalized into MTOC proximal region (<2.5 µm). Scale bar: 5 µm. Data are from at least 149 cells collected during three independent
experiments. Error bar indicates SEM. ****, P < 0.0001, Student’s t test.
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coiled-coil dynein adaptor with a Rab GTPase. We also dem-
onstrate that the dynein adaptor function of CRACR2a is
regulated by calcium in vitro, and that calcium release ac-
companying Jurkat T cell activation results in up-regulation of
CRACR2a–dynein–mediated trafficking. We further found that
CRACR2a forms diffraction-limited cortical puncta at the IS of
activated Jurkat cells. We showed that CRACR2a cortical puncta
require microtubules to detach from the cell cortex and travel
to the MTOC, suggesting that they are involved in an endocytic
transport process.
CRACR2a is a calcium-regulated dynein adaptor protein
Rab45 and CRACR2a, together with Rab11FIP3 and the Ninein
family, constitute a group of adaptor proteins that contain EF-
hands and coiled-coil domains. Recent structural studies have
demonstrated that the coiled-coil domains play crucial roles
in bridging the interaction between dynein and dynactin
(Urnavicius et al., 2015, 2018; Zhang et al., 2017). In contrast, the
role of the EF-hands in these proteins is less clear. Domains
outside of the coiled-coil region in adaptor proteins could facil-
itate or regulate their interactions with dynein–dynactin. The
Hook domain of Hook3, for example, directly binds to the dynein
light-intermediate chain (Zhang et al., 2014; Schroeder and Vale,
2016). It is possible that the EF-hands in Rab45 and CRACR2a
play a similar role. Moreover, EF-hands can assume different
conformations depending on their calcium binding state (Yap
et al., 1999). Interactions between EF-hands and their binding
partners are therefore often calcium regulated (Lewit-Bentley
and Re´ty, 2000). Our study establishes CRACR2a as the first
dynein adaptor protein that responds to calcium changes in vitro
and in cells and shows that the EF-hands are required for this
regulation. CRACR2a, therefore, can serve to connect calcium
signaling to the regulation of dynein function. We demonstrate
that CRACR2a’s calcium regulation couples T cell activation to
dynein-dependent intracellular transport.
The CRACR2a vesicular compartment and its function in T cells
Our data suggest that the intracellular CRACR2a vesicular
compartment, at least in part, is derived through an endocytic
process. Evidence in support of this hypothesis is the observa-
tion that cell surface CD47 pulse labeled with a fluorescent an-
tibody colocalized with GFP-CRACR2a after internalization.
Consistent with Srikanth et al. (2016), we found that the CRACR2a
vesicular compartment moves toward the IS during Jurkat cell
activation, likely due to the repositioning of the MTOC and the
associated endomembrane system (Stinchcombe and Griffiths,
2014). Srikanth et al. (2016) further showed that GFP-CRACR2a
in resting Jurkat cells partially overlaps with the Rab8-positive
trans-Golgi network. However, we find that only CRACR2a, but
neither Rab8A nor Rab11A, responds to ionomycin-induced
calcium increase by further clustering at the MTOC, suggest-
ing that the CRACR2a intracellular vesicular compartment is
distinct from well-characterized endosomal compartments.
The role of CRACR2a and the calcium-induced translocation of
CD47 endosomes to the MTOC in T cell function remains a topic
for future exploration.
A possible role of CRACR2A, microtubules, and dynein in
endocytosis at the T cell IS
In addition to the intracellular vesicular compartment contain-
ing CRACR2A, we observed that CRACR2a forms numerous
cortical puncta, which are dim and diffraction-limited dots at
the cell membrane. The cortical puncta emerge initially
from the lamella edge of the cell and migrate centripetally
with actin retrograde flow (Fig. 6 and Video 3). These puncta
are distinct from the larger CRACR2a vesicles reported by
Srikanth et al. (2016) that occasionally could be observed to
enter into the TIRF view in the central region of the synapse
and move bidirectionally. Although the exact nature of the
CRACR2a cortical puncta remains unclear, we find that they
form through an actin-dependent process at the periphery
of the cell and are visible only within the TIRF illumination
zone (<200 nm). These results suggest that they are localized at
the plasma membrane or the adjacent actin cortex.
We also show that CRACR2a cortical puncta recruit dynein
when they form. We observed discrete events in which
these cortical puncta transitioned from slow actin-mediated
retrograde flow to fast microtubule-based movement toward
the MTOC. If microtubules are depolymerized, then CRACR2a
cortical puncta appear not to be internalized and instead form a
disk at the central region of the IS, accumulating there through
actin retrograde flow. From these observations, we infer that
CRACR2a cortical puncta are first nucleated at the plasma mem-
brane and then become internalized through an endocytosis process.
Collectively, these observations suggest a role of dynein–
dynactin and microtubules in some early steps of CRACR2a-
associated endocytosis (Fig. 9), either in mechanical pulling
that aids in the formation of the endosomal vesicle itself (Day
et al., 2015; Simunovic et al., 2017) or in extracting the vesicle
from the actin-rich cortex and delivering it to the cell interior. In
contrast to the studies documenting involvement of actin in
endosome formation (Mayor et al., 2014; Ferreira and Boucrot,
2017), a role for microtubules in early events of endocytosis is
less well established. An earlier study showed that inhibition of
dynein function or disruption of microtubules suppresses a form
of chorea toxin–induced tubular endosome formation (Day et al.,
2015). This study speculated that a pulling force generated by
dynein might promote the membrane invagination required for
endocytosis, although it was not investigated whether dynein
localizes to these tubular invaginations. Our data suggest that
the CRACR2a cortical puncta eventually mature into endocytic
vesicles, and that dynein and a specific dynein adapter (CRACR2a)
are involved in extracting these vesicles from the actin cortex
and delivering them to the cell interior. More detail on the role
that dynein plays in this form of endocytosis awaits further
studies. However, CRACR2a should provide a useful tool to
tease apart this very specific role of dynein in endocytosis.
Materials and methods
DNA constructs, antibodies, and chemical inhibitors
The cDNA for human Rab45 (NM_152573.3) and CRACR2a (NM_
001144958.1) was synthesized by Genscript. Detailed information
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about the various DNA constructs, antibodies, and inhibitors used
can be found in Table S1.
Protein purification
Rab45 and CRACR2a expressed in bacteria are prone to degra-
dation. To enrich for full-length proteins, we adopted a tandem
affinity purification strategy. Briefly, Rab45 and CRACR2a con-
structs in pET28 vectors were transformed into the Escherichia
coli strain BL21 RIPL (Agilent). Bacterial culture was grown in
Terrific Broth at 37°C until growth reached ∼2.0 OD600. The
temperature was then lowered to 18°C, and the culture was in-
duced overnight with 0.5 mM IPTG. Bacterial pellets were re-
suspended in Ni-A buffer (50 mM Tris-HCl, pH 8.0, 500 mM
NaCl, 2 mMMgCl2, 5% glycerol, 10 mM imidazole, and 3 mM 2-
mercaptoethanol). Cells were lysed using an Emulsiflex press
(Avestin) and clarified at 18,000 rpm using a Sorvall SS-34 rotor
for 60 min at 4°C. Lysates were filtered through a 0.45-µm filter
before loading to a HisTrap FF column (GE Healthcare). The
column was then washed with 20 column volumes (CV) of Ni-A
buffer. Bound protein was elutedwith 10 CVNi-B buffer (20mM
Tris-HCl, pH 8.0, 300mMNaCl, 5% glycerol, 500mM imidazole,
and 3 mM 2-mercaptoethanol). Eluate was then directly loaded
to a StrepTrap HP column (GE Healthcare). The column was
washed with 20 CV wash buffer (20 mM Tris-HCl, pH 8.0,
300 mM NaCl, 2 mM MgCl2, 5% glycerol, and 2 mM DTT), and
the bound protein was eluted with 10 CV elution buffer (20 mM
Tris-HCl, pH 8.0, 300mMNaCl, 2 mMMgCl2, 5% glycerol, 3 mM
desthiobiotin, and 2 mM DTT). Eluted proteins were further
purified with a Superose 6 10/300GL (GE Healthcare) gel fil-
tration column. Peak fractions were pooled and concentrated
and then flash frozen in liquid nitrogen. Dynein and dynactin
were prepared from RPE-1 cells as previously described (Huynh
and Vale, 2017).
EGTA buffered calcium solution
To maintain free calcium concentration at physiologically rele-
vant levels (100 nM to ∼10 µM), it is essential to use an EGTA:
Ca2+ buffer system, which is prepared by mixing EGTA and
CaCl2 at a calculated ratio to achieve the desired free calcium
concentration (Bers et al., 2010). We followed the protocol de-
scribed by Bers et al. (2010) and used the Maxchelator tool that
the authors developed (https://somapp.ucdmc.ucdavis.edu/
pharmacology/bers/maxchelator/CaMgATPEGTA-NIST-Plot.htm)
to calculate the ratio of EGTA and CaCl2 needed to maintain
the desired calcium concentration. The following parameters
were used for the calculation: temperature 25°C, pH 7.3, ionic
0.04 N, 1 mM ATP, and 2 mM Mg2+.
Dynein–dynactin pulldown assay
Pulldown of dynein/dynactin was performed as previously de-
scribed (Huynh and Vale, 2017). Briefly, dynein/dynactin iso-
lated from RPE1 cells were mixed with 20 nM purified Rab45 or
CRACR2a and 15 µl preequilibrated Streptactin Sepharose beads
(GE Healthcare) in 300 µl binding buffer (50 mMHepes, pH 7.4,
20 mM NaCl, 1 mM Mg-Acetate, 10% glycerol, 0.1% NP-40, and
2 mM DTT). The mixture was incubated at 4°C for 1 h. Beads
were pelleted at 1,000× relative centrifugal force for 2 min and
washed four times with 500 µl binding buffer. The proteins
were eluted by boiling in SDS loading buffer for 5 min and
loaded onto SDS-PAGE gel. The amounts of CRACR2a and Rab45
in the pulldown samples were visualized by Coomassie staining.
The amounts of dynein and dynactin were detected via Western
blot with antibodies against dynein heavy chain and the p150
subunit of dynactin, respectively. In the pulldown assay shown
in Fig. 2 A, 2 mM EGTA or EGTA:Ca2+ was added to the binding
buffer to deplete calcium or to maintain a free calcium con-
centration of 2 µM. Information about antibodies used can be
found in Table S1.
Single-molecule motility assay
Microtubules were prepared as previously described (Huynh
and Vale, 2017). Briefly, unlabeled tubulin, biotinylated tubu-
lin, and Alexa Fluor 640–labeled tubulin were mixed at a ratio of
∼5:1:1 in BRB80 (80 mM Pipes, pH 6.8, 1 mM EGTA, and 1 mM
MgCl2). GTP was added to 5 mM final concentration, and the
mixture was incubated at 37°C for 10 min. Taxol was then added
to 20 µM, and microtubules were allowed to polymerize over-
night. Before use, microtubules were spun over a 25% sucrose
Figure 9. A schematic of CRACR2a–dynein–
mediated endocytosis during T cell activation.
Activation of a T cell by an antigen presenting
cell causes increase of intracellular calcium,
which promotes the formation of CRACR2a cor-
tical puncta at the IS. Activation of dynein–
dynactin by CRACR2a facilitates the detachment
of the cortical puncta from the actin cortex
and initiates microtubule minus-end–directed
transport.
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cushion in BRB80 with 10 µM taxol at 20,000 g for 10 min and
resuspended in BRB80 with 10 µM taxol but without EGTA.
For in vitro motility assays, purified Rab45 or CRACR2a was
mixed with dynein–dynactin at a 5:1 ratio in a 25-µl reaction
volume in assay buffer (50mMHepes, pH 7.4, 2 mMmagnesium
acetate, 10% glycerol, and 2 mM DTT) along with 0.1 mg/ml
biotin-BSA, 0.5% pluronic acid F-127, and 0.2 mg/ml κ-casein.
In the motility assay shown in Fig. 2 B, EGTA:Ca2+ buffer
(1 mM EGTA and varying concentrations of CaCl2) was added
to the assay buffer to maintain the desired free calcium con-
centration. The mixture was incubated on ice for at least 1 h.
Flow chambers with attached microtubules were prepared as
described (Schroeder and Vale, 2016). The dynein–dynactin
adaptor complex was then added in the presence of 2 mM ATP
and the Trolox/PCD oxygen scavenging system (Aitken et al.,
2008). TIRF imaging of single molecules was performed on a
Nikon Eclipse TE200-E microscope equipped with an Andor
iXon EM CCD camera, a 100× 1.49-NA objective, and Micro-
Manager software (Edelstein et al., 2014). Exposure conditions
were 200 ms per frame with 1-s interval for 150 frames.
Kymographs were created for randomly selected microtubules
using Fiji (Schindelin et al., 2012), and the number of processive
particles was counted manually.
Cell culture and transduction
U2OS cells and HEK293T cells were cultured in DMEM con-
taining 10% FBS and penicillin/streptomycin/L-glutamine. Ju-
rkat cells were cultured in RPMI 1640 containing 10% FBS and
penicillin/streptomycin/L-glutamine. Lentiviral transduction was
used to create cell lines stably expressing GFP-CRACR2a, and
GFP-positive cells were selected by FACS. Transient transfec-
tion of Jurkat cells was performed with TransIT-Jurkat (Mirus
Bio) following the manufacturer’s protocol.
Peroxisome assay
Unlike other dynein adaptors, Rab45 and CRACR2a contain a
Rab GTPase domain that associates with intracellular mem-
branes through its C-terminal geranylgeranylation. To prevent
concurrent localization of Rab45 and CRACR2a to peroxisomes
and nonperoxisomal membrane compartments, which would
complicate the analysis, we deleted their C-terminal CCX pre-
nylation motifs and cloned them into the pmCherry-FKBP
plasmid. The assay was performed as previously described
(Huynh and Vale, 2017). Briefly, U2OS cells were cotransfected
with mCherry-adaptor-FKBP and PEX-GFP-FRB plasmids. 24 h
after transfection, cells were treated with 0.25 µM rapamycin
for 50 min, and for the last 10 min, cells were stained with
CellMask DeepRed. After washing with PBS twice, cells were
fixed with 4% PFA for 15 min at room temperature. Images were
acquired on a Nikon Eclipse TE200-E spinning disk confocal
microscope equippedwith an Andor iXon EMCCD camera, a 40×
0.95-NA objective, and MicroManager software (Edelstein et al.,
2014). We manually quantified the number of cells exhibiting a
clustered peroxisome phenotype, which is defined as all of the
peroxisome signal in the GFP channel coalescing into a cluster at
the cell center as shown in Fig. 1 F.
Generation of CRACR2a knockout Jurkat cell line
using CRISPR/Cas9
The CRACR2a knockout Jurkat cell line, J.CRACR2a, was gener-
ated by transiently expressing Cas9 and a single guide (sgRNA;
59-ACAGCAGAGGGATTCTTAGG-39) against the CRACR2A exon
8. In brief, the sgRNAwas cloned into the pU6-(BbsI)_CBh-Cas9-
T2A-BFP vector (Addgene; plasmid no. 64323) and electro-
porated into Jurkat cells. Single cells were sorted into 96-well
plates the next day, and monoclonal cell lines were replated to
six-well plates. Successful knockout clones were selected by
screening with immunoblots probed for anti-CRACR2A. Ge-
nomic DNA of the J.CRACR2a was purified and used as a tem-
plate for genotyping. PCR products amplified covering the
sgRNA cutting site were TOPO cloned into pCR2.1 vectors and
sequenced to verify that the genome editing generated prema-
ture stop codons in all the alleles.
T cell activation and calcium stimulation
Glass-bottom 96-well plates (MatriCal) were coated with anti-
CD3ε antibody (clone OKT3) or with IgG isotype control at room
temperature for 2–4 h or at 4°C overnight. In Fig. 8 A, to monitor
TCR internalization, cells were activated by a different anti-CD3
antibody (clone UCHT1), which does not compete with the Alexa
Fluor 647–conjugated antibody used for labeling TCR. Wells
were washed once with PBS. Jurkat T cells were resuspended in
RPMI 1640 (no phenol red, with 25 mM Hepes, pH 7.4) and
rested for 30 min before being dropped onto antibody-coated
wells. For ionomycin stimulation, Jurkat cells were resuspended
in HBSS with 25 mM Hepes, pH 7.4, and added to wells. Cells
were allowed to settle for 15 min, and then ionomycin and CaCl2
were added to final concentrations of 0.5 µM and 1 mM,
respectively.
Confocal imaging of CRACR2a cortical puncta and
vesicular compartments
Jurkat cells expressing GFP-CRACR2a were stimulated as de-
scribed above. For SiR-Tubulin staining, cells were stained with
100 nM SiR-Tubulin in their growth medium for 4 h at 37°C.
Cells were imaged on a Nikon Eclipse TE200-E spinning disk
confocal microscope equipped with an Andor iXon EM CCD
camera, a 100× 1.49-NA oil objective, and MicroManager soft-
ware (Edelstein et al., 2014). To calculate the relative enrichment
of the CRACR2a compartment at theMTOC, a series of z-sections
at 0.3-µm z-intervals was taken. The location of the MTOC was
identified through the SiR-Tubulin channel. The MTOC en-
richment was quantified using Fiji by measuring the mean in-
tensity of GFP signal within 0.5 µm radius of the MTOC, which
was then normalized by the mean intensity of GFP in the
0.5–2.5-µm range around the MTOC. In Fig. 7 B, cells expressing
mCherry-F-tractin and GFP-CRACR2a were labeled with 100 nM
SiR-Tubulin for 4 h. A single frame of F-tractin and SiR-Tubulin
was acquired, and the cells were then imaged continuously using
a 488-nm laser at 6.7 frames/s acquisition rate.
TIRF imaging of CRACR2a cortical puncta at the IS
Jurkat cells expressing GFP-CRACR2a were stimulated as de-
scribed above. TIRF imaging was performed on a Nikon Eclipse
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TE200-E microscope equipped with a motorized TIRF arm, a
Hamamatsu Flash 4 camera, a 100× 1.49-NA oil objective, and
MicroManager software (Edelstein et al., 2014). We found that
the GFP-CRACR2a cortical puncta have a very low signal-to-
noise ratio, possibly due to a high level of diffusive GFP signal
present at the cell membrane. We used relatively low laser
power and long exposure time (800 ms) with 2–4-s imaging
interval to improve the signal-to-noise ratio and reduce photo-
bleaching. To quantify the number of CRACR2a puncta formed,
we used the ImageJ plug-in Spot Counter (http://imagej.net/
SpotCounter) with BoxSize set to 3 and Noise tolerance set to
100. The number of detected spots was quantified over 20
frames, and the average number of spots per frame per
square micrometer was calculated. One or two regions of in-
terest (ROIs) at the periphery of the cell were selected for
quantification. For data shown in Fig. 5 B, chemical inhibitors
(see Table S1 for concentrations used) were added, and cells
were treated for 5 min before being imaged using TIRF. For
K44A dominant-negative dynamin data in Fig. 5 B, K44A Dyn1-
mRFP plasmid was transfected into GFP-CRACR2a–expressing
Jurkat cells, and the number of CRACR2a cortical puncta in
mRFP-positive cells was determined as above. For the nocodazole-
treated cell shown in Fig. 7 C, Jurkat cells were treated with 5 µM
nocodazole for 30 min in RPMI 1640 before being added to
antibody-coated wells. Further treatments with latrunculin A
(LatA) were performed by adding 2 µM final concentration of
LatA to the well and incubating for 5 min. Detailed information
regarding inhibitors and concentrations used can be found in
Table S1.
Antibody internalization assay
For data shown in Fig. 8 (A and B), GFP-CRACR2a Jurkat cells
were washed once with RPMI 1640 (no phenol red, with 25 mM
Hepes, pH 7.4) to remove serum. Cells were then incubated on
ice for 10 min to inhibit endocytosis, before staining with Alexa
Fluor 647–labeled antibodies or transferrin for 20 min on ice.
Cells were then washed twice with cold RPMI 1640 before being
added to anti-CD3–coated wells with prewarmed RPMI 1640.
25–30min after addition of the cells to the wells, z-sections were
acquired using a spinning disk confocal microscope at 0.3-µm
z-interval. For data shown in Fig. 8 C, cells were stained with
Alexa Fluor 647–conjugated anti-CD47 as described above, ex-
cept 1 mMEGTAwas added to deplete calcium from themedium.
Cells were allowed to settle on noncoated glass for 20 min, and
confocal z-sections were acquired. Cells were then treated with
0.5 µM ionomycin and 2 mM CaCl2 for 15 min, and confocal
z-sections were taken. The JACoP plug-in for Fiji was used for
quantifications of the colocalization of internalized receptor in
CRACR2a compartments (Bolte and Cordelières, 2006). A rep-
resentative z-section was selected and an ROI was manually
drawn to exclude cell membrane. After background subtraction
using thresholding, the colocalization was calculated using the
M1 and M2 coefficients analysis. We defined the GFP-CRACR2a
channel as channel A and the Alexa Fluor 647 channel as channel
B. The M2 coefficient was calculated as follows (Bolte and
Cordelières, 2006):
M2 
P
i
Bi,coloc
P
i
Bi
.
Bi is the intensity of pixel i in channel B; Ai is the intensity of
pixel i in channel A; Bi, coloc = Bi if Ai > 0; Bi, coloc = 0 if Ai = 0.
In this experiment, the M2 coefficient represents the amount
of internalized receptor within the CRACR2a compartment
normalized by the total amount of internalized receptor.
Quantification of CD47 internalization in wild-type and
J.CRACR2a Jurkat cells
For data shown in Fig. 8 E, parental or CRACR2a knockout Jurkat
cells were stained with 100 nM SiR-Tubulin for 4 h in growth
medium and washed once with RPMI 1640 (no phenol red, with
25 mM Hepes, pH 7.4) to remove serum. Cells were then incu-
bated on ice for 10 min to inhibit endocytosis, before staining
with FITC-labeled anti-CD47 antibody for 20 min on ice. Cells
were washed once and then incubated at 37°C in RPMI 1640with
0.5 µM ionomycin and 1 mM CaCl2 to stimulate CD47 internal-
ization. To reduce the amount of FITC signal at the cell surface,
which causes high background signal, 0.2% Trypan blue was
added to quench FITC exposed at the cell surface. z-Sections
were acquired using a spinning disk confocal microscope at
0.3-µm z-interval. Image background was determined by mea-
suring mean intensity in an ROI outside of cells. After back-
ground subtraction, quantification of internalized CD47 was
performed by measuring the amount of total FITC signal within
a 2.5-µm circle around the MTOC.
Online supplemental material
Fig. S1 shows SDS gels of purified recombinant proteins and the
effect of calcium or EGTA on the motility of dynein–dynactin-
Rab45. Fig. S2 shows the Western blot of CRACR2a in different
cell lines used in the study. Fig. S3 shows SiR-Tubulin staining of
microtubules as well as translocation of CRACR2a vesicular
compartment toward the IS. Fig. S4 shows the effects of calcium
on subcellular distributions of CRACR2a, Rab8A, and Rab11A.
Fig. S5 shows confocal z-sections of CRACR2a and internalized
anti-CD47. Video 1 shows confocal time-lapse imaging of GFP-
CRACR2a intracellular compartments in Jurkat T cells. Video
2 shows the dynamics of CRACR2a cortical puncta at the T cell
IS. Video 3 shows that CRACR2a cortical puncta migrate with
actin retrograde flow. Video 4 shows that latrunculin treatment
disrupts the retrograde movement of CRACR2a cortical puncta.
Video 5 shows that dynein is recruited to CRACR2a puncta.
Video 6 shows that nocodazole treatment causes accumulation of
CRACR2a cortical puncta at the central region of the IS. Table S1
contains detailed information about the various DNA constructs,
antibodies, and inhibitors used.
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